• Devices
    • Medical Remanufacturing
    • Catalogue
    • Electrophysiology
      • CARTO3
      • EnSite Precision
    • Surgical Instruments
      • Harmonic
    • Purchase of used medical devices
    • eIFU
  • About us
    • Sustainability
    • Economy
    • Safety
    • AMDR
  • Career
  • News
  • Downloads
    • eIFU
  • Contact
  • LogIn
  • English
    • Deutsch
    • English
    • Español
    • Nederlands
    • Français
    • Svenska
    • Dansk
    • Português
    • Norsk Bokmål
    • Belgique
    • Hrvatski
    • Slovenščina
Case Study: How Klinikum Nürnberg Reduces Waste and Carbon Footprint

Case Study: How Klinikum Nürnberg Reduces Waste and Carbon Footprint

by Clemens Köhler | 18. March 2025 | News (en)

The hospital Nürnberg has been committed to sustainability and resource conservation in patient care for over 20 years. As one of Europe’s largest municipal hospitals, with more than 8,400 employees and over 2,000 beds, the hospital follows a clear strategy: reducing...
Sustainability on a Global Scale: Vanguard Supports environmental protection in Bali

Sustainability on a Global Scale: Vanguard Supports environmental protection in Bali

by Clemens Köhler | 4. March 2025 | News (en), Nicht kategorisiert

Plastic Waste Pollutes the Oceans Plastic pollution is one of the greatest environmental challenges of our time. On average, 9 million tons of plastic enter the world’s oceans each year. Coastal regions without proper waste management infrastructure are...
Denmark Allows Reprocessing of Medical Devices

Denmark Allows Reprocessing of Medical Devices

by MarketingVanguard | 26. February 2025 | News (en)

The decision to adopt sustainable and economically viable practices is gaining momentum across the EU healthcare sector. As of January 1, 2025, Danish healthcare facilities can now use reprocessed single-use medical devices. The country officially notified the...
Victory for Science and Sustainability: Bundesrat Overturns Ban on Reprocessed Medical Devices

Victory for Science and Sustainability: Bundesrat Overturns Ban on Reprocessed Medical Devices

by Clemens Köhler | 14. February 2025 | News (en)

We are relieved and pleased by this groundbreaking decision. It confirms that evidence-based arguments and proven safety standards will continue to set the benchmark for medical innovation,” says Ulrike Marczak, CEO of Vanguard AG. “This ensures the...
Sustainability at Vanguard: Three Pillars for the same goal

Sustainability at Vanguard: Three Pillars for the same goal

by Clemens Köhler | 5. February 2025 | News (en)

1. Environmental sustainability: Taking responsibility for the Planet As a manufacturer of remanufactured medical devices, resource conservation is a top priority for us. Through remanufacturing, we extend the lifespan of medical products to maximise their use. The...
The Netherlands allows CS reprocessing from the turn of the year

The Netherlands allows CS reprocessing from the turn of the year

by Clemens Köhler | 23. January 2025 | News (en)

What does it mean in practice? Unlike CE reprocessing, CS reprocessing is carried out without the full obligations of the original manufacturer, as regulated by the respective national legislation. The healthcare facility retains ownership of its devices, which means...
« Older Entries
Next Entries »

Recent Posts

  • Study Quantifies the Carbon Footprint of Atrial Fibrillation Ablation and Highlights Where the Greatest Opportunity for Reduction Lies
  • Remanufacturing Single-Use Devices: the 4 key points to know
  • Problematic Increase in Plastic Waste: Why Medical Remanufacturing Is a Genuine Lever in Healthcare
  • Remanufacturing First, Then Recycling: How Hospitals Can Keep Medical Devices in the Circular Economy
  • Four perspectives, one shared goal: introducing our Executive Support Team

Recent Comments

No comments to show.

Vanguard AG
Landsberger Str. 222
12623 Berlin
Deutschland
Kundenservice: 030 - 318 73 43 - 300

Vanguard Medical Devices Limited
The Scalpel, 18th Floor, 52 Lime Street
London EC3M 7AF
UK

International customer service:
+49 30 - 318 73 43 - 300

© 2026 Vanguard AG. All rights reserved.

Impressum   Datenschutzerklärung   AGB   Kontakt   Datenschutzhinweise für Aktionäre